JG
KYNB

Jefferies Group’s Kyntra Bio KYNB Stock Holding History

Jefferies Group’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-772
Closed -$514K – 1808
2021
Q2 		$514K Buy
+772
New +$445K ﹤0.01% 1159
2020
Q2 		– Sell
-1,168
Closed -$1.01M – 1564
2020
Q1 		$1.01M Hold
1,168
– – 0.01% 994
2019
Q4 		$1.25M Buy
+1,168
New +$1.19M 0.01% 1332

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Jefferies Group's KYNB Position: Q3 2021 in Review

Jefferies Group sold out of Kyntra Bio (KYNB) in Q3 2021, closing a stake of 671 shares — an estimated $446K sold.

Jefferies Group first reported a position in KYNB in Q3 2019 and held it in 4 quarters. The position peaked at $679K in Q1 2020. 164 funds tracked by Wall St. Rank hold KYNB as of Q3 2021.

  • Jefferies Group reported no remaining Kyntra Bio position as of Q3 2021 after selling out during the quarter.
  • Jefferies Group sold 671 Kyntra Bio shares in Q3 2021, an estimated $446K.
  • Jefferies Group first reported a position in Kyntra Bio in Q3 2019 and held it in 4 quarters.
  • Jefferies Group's Kyntra Bio position peaked at $679K in Q1 2020.
  • 164 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2021.

Based on Jefferies Group's 13F filing for Q3 2021, filed 15 Nov 2021.